Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2510265123
Affiliations:
4
Authors:
10
Go to article
Institutions Authors Share
University of Maryland, Baltimore (UMB), United States of America (USA)
6.000000
 0.60
Johns Hopkins Medicine (JHM), JHU, United States of America (USA)
3.000000
 0.30
Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States of America (USA)
1.000000
 0.10
Interested in Oncology and Carcinogenesis?